LRG1 and diabetic kidney disease: The ablation of LRG‐1 in diabetic kidney disease reduces not only glomerular angiogenesis but also attenuates foot process effacement, podocyte loss, and mesangial expansion, suggesting a role of LRG‐1 in the cross‐talk between GEnCs and podocytes [383].